Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

This study has been completed.

Study NCT00003693 Information provided by M.D. Anderson Cancer Center

First Received: November 1, 1999 Last Updated: March 25, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2001
Primary Completion Date:	October 2001 (Final data collection date for primary outcome measure)